TUDOR INVESTMENT CORP ET AL - ENDOLOGIX INC ownership

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$43,000
-62.3%
59,5530.0%0.00%
-66.7%
Q3 2018$114,000
-34.5%
59,553
+93.2%
0.00%
-50.0%
Q2 2018$174,000
+163.6%
30,824
+98.8%
0.01%
+200.0%
Q1 2018$66,000
-80.1%
15,502
-41.7%
0.00%
-71.4%
Q2 2016$331,000
+91.3%
26,571
+28.2%
0.01%
+75.0%
Q1 2016$173,000
-30.5%
20,724
+1.9%
0.00%
-50.0%
Q3 2015$249,000
+10.2%
20,341
+15.8%
0.01%
-20.0%
Q1 2014$226,00017,5620.01%
Other shareholders
ENDOLOGIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$49,653,0005.91%
Essex Woodlands Management, Inc. 1,257,468$21,220,0003.88%
PURA VIDA INVESTMENTS, LLC 205,100$2,515,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,347,113$28,776,0001.11%
First Light Asset Management, LLC 180,963$2,219,0001.10%
ArrowMark Colorado Holdings LLC 2,889,546$35,426,0000.97%
PALISADE CAPITAL MANAGEMENT, LP 2,149,949$26,358,0000.78%
Iguana Healthcare Management, LLC 150,000$1,839,0000.72%
CADIAN CAPITAL MANAGEMENT, LP 1,492,443$18,297,0000.66%
WASHINGTON CAPITAL MANAGEMENT, INC 85,882$1,053,0000.66%
View complete list of ENDOLOGIX INC shareholders